1-3 of 3
Manoj Raghavan, MBBS, PhD
Close
Sort by
Journal Articles

A Phase 1b Study of Eltrombopag and Azacitidine in Patients with High Risk Myelodysplastic Syndromes and Related Disorders

Alex Sternberg, MRCP,FRCPath, Rebecca H. Boucher, BSc, MSc, PhD, Helen C Coulthard, BSc, Manoj Raghavan, MBBS, PhD MRCP, FRCPath, Dominic J. Culligan, MD, Aimee Jackson, BSc, MSc, Catherine Cargo, MB, PhD, Mike Dennis, MD, Marlen Metzner, MSc, Rachel Moore, BA, David Bowen, MD, Paresh Vyas, MRCP, FRCP, FRCPath
Journal: Blood
Blood (2020) 136 (Supplement 1): 10.
https://doi.org/10.1182/blood-2020-134227
Published: 2020
Journal Articles

Clonal Evolution of Multiple TET2 mutations In the Transformation of Chronic Myelomonocytic Leukemia to Acute Myeloid Leukemia and Its Subsequent Relapse

Robert D. Petty, BSc, Farideh Miraki-Moud, Tracy Chaplin, Grossmann Vera, Daverio Andrea, Finlay Macdougall, Maria Ronayne, Bryan D Young, BSc, PhD, Manoj Raghavan, MBBS, PhD
Journal: Blood
Blood (2010) 116 (21): 2699.
https://doi.org/10.1182/blood.V116.21.2699.2699
Published: 2010
Journal Articles

Genome-Wide Micro-Deletions and Amplifications Acquired at Relapse in Acute Myeloid Leukemia.

Manoj Raghavan, MBBS, PhD, MRCP, FRCPath, Manu Gupta, PhD, Tracy Chaplin, MSc, Sabah Khalid, PhD, T. Andrew Lister, Bryan D Young, PhD
Journal: Blood
Blood (2009) 114 (22): 166.
https://doi.org/10.1182/blood.V114.22.166.166
Published: 2009